Monday, 16 September 2019

Pharma News

  • HSA regulatory conference under way in Singapore

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2013

    Singapore: Health Sciences Authority (HSA), which is the national regulator for health products in Singapore, inaugurated the Asia Regulatory Conference 2013 in the island nation for the fi...Read more

  • China SFDA drug lab gets WHO prequalification

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 10 Jan, 2013

    Singapore: The World Health Organization (WHO) has included China's National Institutes for Food and Drug Control (NIFDC) to the list of prequalified quality control laboratories. This in...Read more

  • Taiwan: Fosters global partnerships

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 15 May, 2013

    A small island country, Taiwan, has implemented policies that indicate its seriousness towards elevating its bioscience industry. Recently, Taiwan inaugurated biotech development consortium...Read more

  • BMS-Pfizer stroke drug gets Japanese nod

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 27 Dec, 2012

    Singapore: Bristol-Myers Squibb and Pfizer announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved Eliquis (apixaban) for the prevention of ischemic stroke an...Read more

  • World leader discuss health challenges at Qatar

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 11 Dec, 2013

    Singapore: World leaders and policy makers have gathered in Doha, Qatar, to discuss innovative solutions to the most pressing global health challenges at the inaugural World Innovation Summ...Read more

  • Aussie firm Mayne to acquire GSK's Kapanol

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jan, 2013

    Singapore: Australia's Mayne Pharma plans to acquire Kapanol and related assets in Australia from GlaxoSmithKline (GSK). Under the terms of the agreement, Mayne Pharma will acquire the Kap...Read more

  • GSK CEO accompanies UK PM on China visit

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 02 Dec, 2013

    Singapore: After facing a storm of controversy in China, Sir (Dr) Andrew Witty, CEO, GlaxoSmithKline (GSK) visited the country accompanying UK Prime Minister Mr David Cameron on his trade m...Read more

  • How Chinese economy will impact its life sciences?

    Pharma |  Opinion | By BioSpectrum Bureau  | 0 Comment | 13 Mar, 2013

    During a January 2013 economic forum in Beijing, Lou Jiwei, chairman of the China Investment Corporation (CIC), presented forecasts that China's economy could grow at more than eight percen...Read more

  • Israel firm gets FDA nod for insulin trials in the US

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 20 May, 2013

    Singapore: Israel-based Oramed Pharmaceuticals received approval from the US FDA for its Investigational New Drug Application (INDA) for ORMD-0801, its oral insulin capsule. Oramed's ORMD-...Read more

  • Nexavar seeks marketing authorization in Japan

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

    Singapore: Bayer HealthCare has submitted an additional application for marketing authorization to the Ministry of Health, Labour and Welfare (MHLW) in Japan for Nexavar (Sorafenib) tablets...Read more

  • ShangPharma completes in-house merger

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 28 Mar, 2013

    Singapore: ShangPharma, a leading China-based pharmaceutical and biotechnology R&D outsourcing company, has completed the merger contemplated by the previously announced agreement and p...Read more

  • Shinogi starts supply of Pirespa to Ildong

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 16 Oct, 2012

    Singapore: Osaka-based Shionogi has began to supply Pirespa 200mg tablet (pirfenidone) to Ildong Pharmaceutical, which is headquartered in Seoul, for the treatment of idiopathic pulmonary f...Read more

  • BMS buys Amylin to strengthen diabetes portfolio

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2012

    Singapore: Bristol-Myers Squibb (BMS) and AstraZeneca expanded their diabetes alliance through BMS's acquisition of Amylin Pharmaceuticals. It was recently announced that BMS will acquire ...Read more

  • Why does NYSE want to delist China Botanic?

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 06 Feb, 2013

    Singapore: China Botanic Pharmaceutical received a notice of failure to satisfy continued listing standards from the New York Stock Exchange (NYSE) stock exchange. NYSE had previously warne...Read more

  • Former Takeda CEO joins EnVivo Pharmaceuticals

    Pharma |  Influencers | By BioSpectrum Bureau  | 0 Comment | 12 Jul, 2013

    Singapore: EnVivo Pharmaceuticals, US based drug developer of central nervous system has appointed Dr. Deborah Dunsire, as president and chief executive officer. Dr. Dunsire served as presi...Read more

  • Is China bioscience really slowing down?

    Pharma |  Opinion | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

    Is China bioscience slowing down? From the numbers that have been put together by the BioSpectrum Asia Pacific Bioscience Industry Survey 2013, it does look so. However, a little deeper loo...Read more

  • Pharma Logistics China from October 23

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2012

    Singapore: The 2nd Pharma Logistics China 2012 will be held from October 23 till October 25 at Shanghai, China. The conference is the foremost and only gathering of heads from leading biot...Read more

  • Bio-XCell offers customized tech parks in Malaysia

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 29 Aug, 2013

    Singapore: Malaysian Bio-XCell, a joint venture between Malaysian Biotechnology Corporation and UEM Sunrise, Malaysia, launched Titanium Scheme, the next phase of bioscience parks that are ...Read more



Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls